| Translational - CNIO - page 7
Let

Home | News | Translational | Page 7

Translational

Translational
 14.01.2015 Clinical Cancer Research. CNIO scientist associate rare variants of a gene with side effects from chemotherapy with paclitaxel The research is published by 'Clinical Cancer Research' Translational
 14.11.2014 European Urology. International study concludes conventional therapies are less efficient in prostate cancer patients carrying ‘BRCA’ mutations Prostate cancer patients carrying inherited mutations in the BRCA genes respond less well to... CNIO scientist challenge the efficacy of FOLFIRI in a colorectal cancer subtype under question Translational
 06.11.2014 Nature Medicine. CNIO scientist challenge the efficacy of FOLFIRI in a colorectal cancer subtype under question The current classification system for colorectal cancer, which is based on genetic expression... CNIO successfully completes its first clinical trial on HER-2-Negative breast cancer with Nintedanib Translational
 09.09.2014 British Journal of Cancer. CNIO successfully completes its first clinical trial on HER-2-Negative breast cancer with Nintedanib The experimental drug nintedanib, combined with standard chemotherapy with paclitaxel, causes a... Translational
 29.04.2014 Clinical Cancer Research. CNIO team presents a new strategy to personalize cancer therapies Tumour cells can accumulate hundreds or even thousands of DNA mutations which induce the growth and... Translational
 26.02.2014 Immunity | Science Translational Medicine. CNIO researchers discover two new strategies for the treatment of psoriasis Almost ten years ago, the group led by Erwin Wagner, currently at the Spanish National Cancer... Four years of clinical trials at the CNIO Translational
 02.12.2013 Four years of clinical trials at the CNIO Madrid (Spain), December 2, 2013.Four years ago, the Spanish National Cancer Research Centre (CNIO)... A study led by the CNIO validates a new anti-cancer therapy based on cell division Translational
 15.11.2013 Cancer Research. A study led by the CNIO validates a new anti-cancer therapy based on cell division Aurora-A is a protein involved in the cell division process that is highly expressed or synthesised... CNIO and the Niño Jesús Hospital create a Paediatric Clinical Trials Research Unit Translational
 02.10.2013 CNIO and the Niño Jesús Hospital create a Paediatric Clinical Trials Research Unit The Spanish National Cancer Research Centre (CNIO), via its Clinical Research Programme, together...
1 … 5 6 7 8

Up